Treatment of pediatric, adolescent, and young adult patients with fusion-positive Alveolar Rhabdomyosarcoma infiltrating regional lymph nodes in the European CWS-2002P and RMS 2005 studies and the soft tissue sarcoma registry

Background Patients with alveolar rhabdomyosarcoma (ARMS) with regional lymph node involvement (N1) are defined as “very-high-risk rhabdomyosarcoma” in Europe. Different chemotherapy regimens were used in European study protocols. Methods Patients with FOXO1 fusion-positive N1 ARMS registered in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heinz, Amadeus Tilman (VerfasserIn) , Ciuffolotti, Melissa (VerfasserIn) , Merks, Johannes H. M. (VerfasserIn) , Schönstein, Anton (VerfasserIn) , Minard-Colin, Véronique (VerfasserIn) , Fuchs, Jörg (VerfasserIn) , Guillen, Gabriela (VerfasserIn) , Timmermann, Beate (VerfasserIn) , Vokuhl, Christian (VerfasserIn) , Koscielniak, Ewa (VerfasserIn) , Chisholm, Julia C. (VerfasserIn) , Sparber-Sauer, Monika (VerfasserIn) , Bisogno, Gianni (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 2025
In: Pediatric blood & cancer
Year: 2025, Jahrgang: 72, Heft: 3, Pages: 1-12
ISSN:1545-5017
DOI:10.1002/pbc.31476
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/pbc.31476
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.31476
Volltext
Verfasserangaben:Amadeus T. Heinz, Melissa Ciuffolotti, Johannes H. M. Merks, Anton Schönstein, Véronique Minard-Colin, Jörg Fuchs, Gabriela Guillen, Beate Timmermann, Christian Vokuhl, Ewa Koscielniak, Julia C. Chisholm, Monika Sparber-Sauer, Gianni Bisogno

MARC

LEADER 00000naa a2200000 c 4500
001 1927868033
003 DE-627
005 20250610112654.0
007 cr uuu---uuuuu
008 250610s2025 xx |||||o 00| ||eng c
024 7 |a 10.1002/pbc.31476  |2 doi 
035 |a (DE-627)1927868033 
035 |a (DE-599)KXP1927868033 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Heinz, Amadeus Tilman  |e VerfasserIn  |0 (DE-588)1204208840  |0 (DE-627)1689517824  |4 aut 
245 1 0 |a Treatment of pediatric, adolescent, and young adult patients with fusion-positive Alveolar Rhabdomyosarcoma infiltrating regional lymph nodes in the European CWS-2002P and RMS 2005 studies and the soft tissue sarcoma registry  |c Amadeus T. Heinz, Melissa Ciuffolotti, Johannes H. M. Merks, Anton Schönstein, Véronique Minard-Colin, Jörg Fuchs, Gabriela Guillen, Beate Timmermann, Christian Vokuhl, Ewa Koscielniak, Julia C. Chisholm, Monika Sparber-Sauer, Gianni Bisogno 
264 1 |c March 2025 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Zuerst veröffentlicht: 10. Dezember 2024 
500 |a Gesehen am 10.06.2025 
520 |a Background Patients with alveolar rhabdomyosarcoma (ARMS) with regional lymph node involvement (N1) are defined as “very-high-risk rhabdomyosarcoma” in Europe. Different chemotherapy regimens were used in European study protocols. Methods Patients with FOXO1 fusion-positive N1 ARMS registered in the CWS-2002P study, the EpSSG RMS 2005 study, and SoTiSaR were retrospectively investigated. Patients received systemic treatment with chemotherapy (CHT) and local treatment of primary tumor (PT) and involved lymph nodes (LN) with radiotherapy (RT) and/or surgery. Kaplan-Meier estimators and Cox regression were used to examine event-free survival (EFS) and overall survival (OS) according to prognostic factors and treatment. Results A total of 156 patients registered in RMS 2005 (n = 99), CWS-2002P (n = 20), and SoTiSaR (n = 37) between 2003 and 2020 were eligible for this analysis. Median age at diagnosis was 10.2 years [0.1-21.9]. Treatment comprised CHT with IVADo (ifosfamide, vincristine, actinomycin-D, doxorubicin, n = 93; 60%), VAIA (vincristine, actinomycin-D, ifosfamide, adriamycin/doxorubicin, n = 53; 34%) or other regimens (n = 10; 6%); resection of the PT (n = 89; 57%), LN sampling or dissection (n = 92; 59%), and/or RT (n = 139; 89%). Maintenance treatment (MT) was added in n = 99/135 (73%) patients who achieved complete remission. Five-year EFS and OS of the cohort were 45% and 47%, respectively. Age and tumor size were independent prognostic factors for EFS. Local treatment applied to the LN with surgery, RT or both significantly improved EFS (p = 0.02) and OS (p = 0.04), with no difference between the modalities (p = 0.7). Conclusions Patients with fusion-positive N1 ARMS carry a poor prognosis. Adequate local treatment of LN improved survival. 
650 4 |a alveolar rhabdomyosarcoma 
650 4 |a chemotherapy 
650 4 |a fusion-positive rhabdomyosarcoma 
650 4 |a local treatment 
650 4 |a lymph node involvement 
650 4 |a pediatric/adolescent oncology 
700 1 |a Ciuffolotti, Melissa  |e VerfasserIn  |4 aut 
700 1 |a Merks, Johannes H. M.  |e VerfasserIn  |4 aut 
700 1 |a Schönstein, Anton  |d 1992-  |e VerfasserIn  |0 (DE-588)1235701484  |0 (DE-627)1760713155  |4 aut 
700 1 |a Minard-Colin, Véronique  |e VerfasserIn  |4 aut 
700 1 |a Fuchs, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Guillen, Gabriela  |e VerfasserIn  |4 aut 
700 1 |a Timmermann, Beate  |e VerfasserIn  |4 aut 
700 1 |a Vokuhl, Christian  |e VerfasserIn  |4 aut 
700 1 |a Koscielniak, Ewa  |e VerfasserIn  |4 aut 
700 1 |a Chisholm, Julia C.  |e VerfasserIn  |4 aut 
700 1 |a Sparber-Sauer, Monika  |e VerfasserIn  |4 aut 
700 1 |a Bisogno, Gianni  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Pediatric blood & cancer  |d New York, NY : Wiley, 2004  |g 72(2025), 3 vom: März, Artikel-ID e31476, Seite 1-12  |h Online-Ressource  |w (DE-627)37682798X  |w (DE-600)2130978-4  |w (DE-576)11281610X  |x 1545-5017  |7 nnas  |a Treatment of pediatric, adolescent, and young adult patients with fusion-positive Alveolar Rhabdomyosarcoma infiltrating regional lymph nodes in the European CWS-2002P and RMS 2005 studies and the soft tissue sarcoma registry 
773 1 8 |g volume:72  |g year:2025  |g number:3  |g month:03  |g elocationid:e31476  |g pages:1-12  |g extent:12  |a Treatment of pediatric, adolescent, and young adult patients with fusion-positive Alveolar Rhabdomyosarcoma infiltrating regional lymph nodes in the European CWS-2002P and RMS 2005 studies and the soft tissue sarcoma registry 
856 4 0 |u https://doi.org/10.1002/pbc.31476  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.31476  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250610 
993 |a Article 
994 |a 2025 
998 |g 1235701484  |a Schönstein, Anton  |m 1235701484:Schönstein, Anton  |d 850000  |d 851600  |e 850000PS1235701484  |e 851600PS1235701484  |k 0/850000/  |k 1/850000/851600/  |p 4 
999 |a KXP-PPN1927868033  |e 473287116X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Heinz, Amadeus Tilman","family":"Heinz","given":"Amadeus Tilman","role":"aut"},{"given":"Melissa","role":"aut","family":"Ciuffolotti","display":"Ciuffolotti, Melissa"},{"display":"Merks, Johannes H. M.","family":"Merks","role":"aut","given":"Johannes H. M."},{"display":"Schönstein, Anton","family":"Schönstein","role":"aut","given":"Anton"},{"display":"Minard-Colin, Véronique","given":"Véronique","role":"aut","family":"Minard-Colin"},{"given":"Jörg","role":"aut","family":"Fuchs","display":"Fuchs, Jörg"},{"display":"Guillen, Gabriela","family":"Guillen","given":"Gabriela","role":"aut"},{"family":"Timmermann","role":"aut","given":"Beate","display":"Timmermann, Beate"},{"role":"aut","given":"Christian","family":"Vokuhl","display":"Vokuhl, Christian"},{"role":"aut","given":"Ewa","family":"Koscielniak","display":"Koscielniak, Ewa"},{"display":"Chisholm, Julia C.","given":"Julia C.","role":"aut","family":"Chisholm"},{"family":"Sparber-Sauer","given":"Monika","role":"aut","display":"Sparber-Sauer, Monika"},{"display":"Bisogno, Gianni","family":"Bisogno","given":"Gianni","role":"aut"}],"title":[{"title":"Treatment of pediatric, adolescent, and young adult patients with fusion-positive Alveolar Rhabdomyosarcoma infiltrating regional lymph nodes in the European CWS-2002P and RMS 2005 studies and the soft tissue sarcoma registry","title_sort":"Treatment of pediatric, adolescent, and young adult patients with fusion-positive Alveolar Rhabdomyosarcoma infiltrating regional lymph nodes in the European CWS-2002P and RMS 2005 studies and the soft tissue sarcoma registry"}],"language":["eng"],"physDesc":[{"extent":"12 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1002/pbc.31476"],"eki":["1927868033"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"March 2025"}],"name":{"displayForm":["Amadeus T. Heinz, Melissa Ciuffolotti, Johannes H. M. Merks, Anton Schönstein, Véronique Minard-Colin, Jörg Fuchs, Gabriela Guillen, Beate Timmermann, Christian Vokuhl, Ewa Koscielniak, Julia C. Chisholm, Monika Sparber-Sauer, Gianni Bisogno"]},"recId":"1927868033","note":["Zuerst veröffentlicht: 10. Dezember 2024","Gesehen am 10.06.2025"],"relHost":[{"part":{"extent":"12","text":"72(2025), 3 vom: März, Artikel-ID e31476, Seite 1-12","volume":"72","pages":"1-12","year":"2025","issue":"3"},"id":{"doi":["10.1002/(ISSN)1545-5017"],"zdb":["2130978-4"],"issn":["1545-5017"],"eki":["37682798X"]},"origin":[{"publisherPlace":"New York, NY","publisher":"Wiley","dateIssuedKey":"2004","dateIssuedDisp":"2004-"}],"disp":"Treatment of pediatric, adolescent, and young adult patients with fusion-positive Alveolar Rhabdomyosarcoma infiltrating regional lymph nodes in the European CWS-2002P and RMS 2005 studies and the soft tissue sarcoma registryPediatric blood & cancer","recId":"37682798X","title":[{"title_sort":"Pediatric blood & cancer","title":"Pediatric blood & cancer"}],"pubHistory":["42.2004 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Pediatric blood and cancer"}],"note":["Gesehen am 13.05.14"]}]} 
SRT |a HEINZAMADETREATMENTO2025